GENOVA is a global CRO with over 20 years of experience, providing a wide range of healthcare research and drug development services and solutions – from preclinical stages to market access. GENOVA offers full support to Pharma, Biotech, and Medical Device companies and institutions.
FREEARCS PHARMA SERVICES is a CRO based in Paris region and specialized in Clinical Research.
We support healthcare project leaders, including biotech, start-ups, medtech, Lab Pharma companies, international and local CROs, as well as Academic and scientific research stakeholders, in the set-up, management, and execution of their clinical studies.
We support our Partners in conducting Interventional, Observational, and Epidemiological studies, covering Real-World Data and Real-World Evidence (RWD/RWE) Projects. Our expectise extends to Drugs, Medical Devices, and Healthcare Products.
Our approach is based on a human-centered model, working hand in hand, combining technical expertise with true proximity and understanding.
Our activities are conducted in full compliance with French and international regulatory requirements, Good Clinical Practice (ICH/GCP), and applicable quality standards.
FREEARCS PHARMA SERVICES provides independent, agile, and quality-driven support, tailored to innovative projects and organizations of all sizes.
Paspigioni is a full-service CRO that offers cost-effective, high-quality clinical trials from Phases I to IV. We operate across emerging markets in Central and Eastern Europe, the Balkans, and Central Asia, ensuring a competitive edge for our partners. Using a CRO-in-a-box approach, Paspigioni launches and manages trials in different countries and supports biotech and pharma companies with efficient solutions. We guide our partners through new clinical landscapes, offering operational excellence and reliable results. We enable access to untapped patient populations, and provide local market expertise and a clear regulatory path. We focus on transparency, partnership, quality and trust across all stages of our work.
Comac Medical is a trusted full service CRO established in Bulgaria in 1997 for end-to-end clinical trial services, delivering faster, smarter, and high-quality trials from Phase I to IV. We provide tailored Contract Research Organization (CRO) services that help Biotech and Pharmaceutical companies navigate complex regulatory landscapes, optimize study timelines, and achieve successful trial outcomes.
With almost 30 years of experience, operating globally, we have conducted more than 1500 studies across a variety of therapeutic areas with a differentiated expertise and track record for indications within oncology, dermatology, gastroenterology, and respiratory diseases.
In May 2025 – Comac Medical Group (“Group”), based in the UK has acquired ILIFE Consulting (“ILIFE”), a specialized CRO headquartered in Paris, France, renowned for its expertise in oncology, rare diseases, and complex biotech clinical trials.
Currently Comac Medical has more than 250 fulltime employees.
HEVA is a CRO with approximately 100 experts offering dual expertise:
In clinical project management (clinical trials, compassionate use programs, observational studies, etc.) and;
In the analysis of medical-administrative (SNDS/PMSI) and clinical databases using innovative approaches (such as machine learning, data visualization, comparative methods, etc.).
Alithia is a proudly Australian-owned, full-service CRO.
At Alithia, we understand that successful clinical trials require more than operational delivery, they require trusted partnership, strategic insight, and unwavering commitment.
Our team works collaboratively with clients to navigate the complexities of clinical development while maintaining the highest standards of quality, efficiency, and compliance.
Supported by experienced Senior Clinical research professionals, we bring deep expertise across multiple therapeutic areas, all phases of clinical research and experience in relevant regulatory jurisdictions.
With a proactive and solutions-focused approach, we are dedicated to delivering reliable outcomes and advancing programs with confidence from study start-up through to completion.
